Global Health Clinics Ltd.
LRSNF
$0.0011
-$0.2209-99.51%
| Weiss Ratings | LRSNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E | |||
| Reward Grade | E | |||
| Rating Factors | LRSNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Very Weak | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Very Weak | |||
| Beta / Standard Deviation | LRSNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.39 | |||
| Price History | LRSNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | 0.00% | |||
| 90-Day Total Return | 0.00% | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | -99.50% | |||
| 2-Year Total Return | -99.50% | |||
| 3-Year Total Return | -99.84% | |||
| 5-Year Total Return | -99.87% | |||
| 52-Week High % Change | 0.00% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | LRSNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.00 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Apr 29, 2024 | |||
| 52-Week High Price (Date) | Apr 29, 2024 | |||
| Valuation | LRSNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 65.17K | |||
| Enterprise Value | 1.29M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.09 | |||
| Earnings Per Share Growth | -11.50% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.17 | |||
| Price/Book (Q) | 0.00 | |||
| Enterprise Value/Revenue (TTM) | 18.68 | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -1.57 | |||
| Enterprise Value/EBIT | -1.57 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | LRSNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 9.39M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | LRSNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | (604) 283-1722 | |||
| Address | 837 West Hasting Street Vancouver, BC V6C 3N6 | |||
| Website | globalhealthltd.ca | |||
| Country | Canada | |||
| Year Founded | 2013 | |||
| Profitability | LRSNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -1,187.10% | |||
| Profit Margin | -1,379.56% | |||
| Management Effectiveness | LRSNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -864.27% | |||
| Return on Equity | -- | |||
| Income Statement | LRSNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 59.70K | |||
| Total Revenue (TTM) | 59.70K | |||
| Revenue Per Share | $0.01 | |||
| Gross Profit (TTM) | 45.70K | |||
| EBITDA (TTM) | -708.30K | |||
| EBIT (TTM) | -708.70K | |||
| Net Income (TTM) | -823.60K | |||
| Net Income Avl. to Common (TTM) | -823.60K | |||
| Total Revenue Growth (Q YOY) | -9.03% | |||
| Earnings Growth (Q YOY) | -17.27% | |||
| EPS Diluted (TTM) | -0.09 | |||
| EPS Diluted Growth (Q YOY) | -17.65% | |||
| Balance Sheet | LRSNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 27.20K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 34.70K | |||
| Total Preferred Equity (Q) | 0.07 | |||
| Total Equity (Q) | -2.54M | |||
| Current Ratio (Q) | 0.013 | |||
| Book Value Per Share (Q) | -$0.28 | |||
| Total Assets (Q) | 35.70K | |||
| Total Current Liabilities (Q) | 2.58M | |||
| Total Debt (Q) | 1.22M | |||
| Total Liabilities (Q) | 2.58M | |||
| Total Common Equity (Q) | -2.62M | |||
| Cash Flow | LRSNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | 319.30K | |||
| Net Change in Cash (TTM) | -18.00K | |||
| Levered Free Cash Flow (TTM) | -95.20K | |||
| Cash from Operations (TTM) | -337.30K | |||
